The DNA structures underlying PARP inhibitor toxicity in BRCA2-deficient cells remain unclear. Here, the authors identify G-quadruplex structures as determinants of PARP inhibitor sensitivity and find that the BRCA2 and HAPSTR1–HUWE1 pathways suppress G4s to influence the PARP inhibitor response.